Novo Nordisk drug becomes world's top-selling diabetes medicine

Ozempic reached DKK 12bn (USD 1.7bn) in sales during the first quarter of this year, which no other diabetes treatment can match.

Photo: Novo Nordisk / PR

Diabetes treatment Ozempic has become the star of the show at Novo Nordisk after its sales skyrocketed in Q1.

Danish financial daily Børsen reports that sales of the drug have increased by 70 percent and surpassed DKK 12bn (USD 1.7bn) in sales during the first three months of the year.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs